LINDA CALDERON: Open Payments
NPI 1982097846 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$562 in 11 payments from 7 companies in 2025. Trend: 2023 $708 · 2024 $1,154 · 2025 $562
Food & beverage: $483Education: $79
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $212 |
| Profound Medical Corp. | 1 | $172 |
| Sumitomo Pharma America, Inc. | 4 | $87 |
| COLOPLAST CORP | 1 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Endo USA, Inc. | 1 | $19 |
| Teleflex LLC | 1 | $18 |
Products named: Tulsa-Pro, RYBREVANT, GEMTESA, ERLEADA, Titan, Nubeqa, AVEED, BARRIGEL.
Industry payments across NY — which companies pay providers there.
